Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications

• 主要な著者: András Incze (著者), Zoltán Kaló (著者), Jaime Espín (著者), Éva Kiss (著者), Sophia Kessabi (著者), Louis P. Garrison (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: External reference pricing (ERP) is used to set pharmaceutical prices to improve affordability, but its application may have negative consequences on patient access-thus, equity-across countries and on global innovation. With the United States contemplating ERP, negative effects could be...